Revolution Medicines的股票因'令人鼓舞'的第一阶段肺癌试验数据而上涨 Revolution Medicines (RVMD) 的股票在最近的星期一交易中上涨了5.9%,此后公司表示zoldonrasib的1期试验初步数据,这是一种治疗KRAS G12D突变非小细胞肺癌的药物。 MT Newswires04/28 23:33 为什么癌症药物开发公司Revolution Medicines的股票在周一...
RVMD Stock Earnings: Revolution Medicines Beats EPS for Q1 2024 Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development 3 Biotech Stocks That Could Boom or Bust by 2025 More Articles Previous Close $40.50 Market Cap 7.53B PE Ratio -10.90 EPS -3.5781 Volume (Avg. Vol.)...
RVMD Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +22.33% Revolution Medicines, Inc. price and volume Combination chart with 2 data series. Chart represents Revolution Medicines, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The ...
机构预期$Revolution Medicines(RVMD.US)$2024Q4预计实现营收34.62万美元,同比减少53.35%;预期每股收益-0.99美元,亏损同比缩窄12.99%。上述数据使用的会计准则为US-GAAP。 02-20 OYang: #药闻简讯#$Revolution Medicines(RVMD)$使用 RMC-6236单药疗法清除 ctDNA中的突变 KRAS在第二线及转移后的治疗胰腺癌。90%...
Revolution Medicines Stock Performance As of 21-Feb-2025, Revolution Medicines’s stock price is $41.34. Its current market cap is $7.64B with 185M shares. (As of Friday Closing) Stock PricePrevious Close52 wk RangeMarket CapSharesAverage VolumeEPS $41.34 $42.26 $28.95 - $62.40 $7.64B 185...
Stock Quote & ChartAnalyst Coverage SEC Filings EQRx Acquisition Information IRS Form 8937 for EQRx Shareholders Resources Investor FAQsEmail AlertsContact IR Corporate Profile Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted can...
RVMD Revolution Medicines, Inc. 39.12 41.21 -5.06% 0.76% RVMDW Revolution Medicines, Inc. WT EXP 121726 0.10 0.14 -26.89% 0.00% TRDA Entrada Therapeutics, Inc. 10.81 13.05 -17.18% 0.23% BCYC Bicycle Therapeutics plc 9.69 12.40 -21.84% 0.50% REPL Replimune Group, Inc. 11.66 12.70 -8.19%...
Revolution Medicines 的核心竞争力在于其一系列直接靶向 RAS(ON) 的抑制剂,其中三款已进入临床开发阶段,并展现出令人鼓舞的早期结果。 1. Daraxonrasib (RMC-6236, 多选择性抑制剂): 描述: 一种口服的、RAS(ON)多选择性(multi-selective)抑制剂,旨在抑制多种 RAS 变体(包括突变型和可能的野生型)的活性状态 ...
Revolution Medicines分析师评级 & 目标价预测 美股市场个股详情 RVMD Revolution Medicines 添加自选 32.870 -1.730-5.00% 收盘价 04/03 16:00 (美东) 33.010 +0.140+0.43% 盘后20:01 (美东) 61.11亿总市值-9.18市盈率TTM 33.800最高价32.780最低价190.56万股成交量32.980今开34.600昨收6324.53万成交额1.13%...
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com